Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Alievio
company
About
Alievio is a North Carolina-based innovative glaucoma medical device company.
- 1 - 10
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $5.70M
- Industries
- Health Care,Medical,Medical Device
- Founded date
- Jan 1, 2010
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Alievio is a North Carolina-based innovative glaucoma medical device company. The company has introduced the first glaucoma therapy that will not only circumvent the complications present with glaucoma surgery. It also provides ophthalmologists with the first tool that can stop the progression of glaucoma.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$7.39M
Alievio has raised a total of
$7.39M
in funding over 2 rounds. Their latest funding was raised on
Apr 10, 2018 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 10, 2018 | Series A | $5.70M | 1 | — | — | Detail |
| Feb 17, 2016 | Grant | $1.36M | 1 |
National Science Foundation
|
— | Detail |
| Nov 25, 2014 | Grant | $179.99K | 1 |
National Science Foundation
|
— | Detail |
| Dec 18, 2012 | Grant | $149.97K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
3
2
Alievio is funded by 2 investors.
National Science Foundation
and IMAF Coastal Plain
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
